Faculty
McGill.CA / McGill Breast Outcomes Research Group (mBORG)

Publications

Below is a selection of peer-reviewed publications authored by members of the McGill Breast Outcomes Research Group from 2022 to 2025. These works reflect our collaborative research in breast surgical oncology, with a focus on clinical outcomes, patient-centered care, health services, and cancer prevention.

Trainees supervised by mBORG faculty are indicated with an asterisk (*).

  1. Faleh S, Prakash I, Salehi A, Khan H, Basik M, Boileau JF, Tejera D*, Panet F, Martel K, Meterissian S, Wong SM. Preoperative Factors that Predict Pathologic Nodal Involvement in Early-stage HER2+ Breast Cancer: Selecting cT1cN0 Patients for Treatment with Neoadjuvant Chemotherapy versus Upfront surgery. Breast Cancer Res Treat. 2024 Jun;205(2):303-312. doi: 10.1007/s10549-024-07251-8. PMID: 38381275.
  2. Alhassan B*, Rjeily MB*, Villareal-Corpuz V, Prakash I, Basik M, Boileau JF, Martel K, Pollak M, Foulkes WD, Wong SM. Awareness and Candidacy for Endocrine Prevention and Risk Reducing Mastectomy in Unaffected High-Risk Women Referred for Breast Cancer Risk Assessment. Ann Surg Oncol. 2024 Feb;31(2):981-987. doi: 10.1245/s10434-023-14566-1. PMID: 37973648.
  3. Wong SM, Apostolova C*, Eisenberg E*, Foulkes WD. Counselling Framework for Germline BRCA1/2 and PALB2 Carriers Considering Risk-Reducing Mastectomy. Curr Oncol. 2024 Jan 9;31(1):350-365. doi: 10.3390/curroncol31010023. PMID: 38248108.
  4. Apostolova C*, Ferroum A*, Alhassan B*, Prakash I, Basik M, Boileau JF, Martel K, Meterissian S, Villareal Corpuz V, Wong N, Foulkes WD, Wong SM. Timing of Genetic Testing in BRCA1/2 and PALB2-associated Breast Cancer: Preoperative Result Disclosure Increases Uptake of Risk-reducing Mastectomy and Reduces Unnecessary Exposure to Radiotherapy. Eur J Surg Oncol. 2024 Jun;50(6):108324. doi: 10.1016/j.ejso.2024.108324. PMID: 38636249.
  5. Di Lena É*, Iny E*, Wong SM, Bassel M*, Shah A, Basik M, Boileau JF, Martel K, Meterissian S, Prakash I. Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study. Ann Surg Oncol. 2024 Oct;31(10):6786-6794. doi: 10.1245/s10434-024-15716-9. PMID: 38969849.
  6. Di Lena É*, Wong SM, Iny E*, Mashal S*, Basik M, Boileau JF, Martel K, Bassel MA*, Meterissian S, Prakash I. Oncologic Safety of Breast-conserving Surgery after Neoadjuvant Chemotherapy in Patients with Multiple Ipsilateral Breast Cancer: A Retrospective Multi-institutional Cohort Study. Eur J Surg Oncol. 2024 Jun;50(6):108266. doi: 10.1016/j.ejso.2024.108266. PMID: 38492259.
  7. Apostolova C*, Ferroum A*, Alhassan B*, Prakash I, Viezel-Mathieu A, Basik M, Boileau JF, Meterissian S, Wong N, Foulkes WD, Wong SM. Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy. Ann Surg Oncol. 2024 Jan;31(1):356-364. doi: 10.1245/s10434-023-14418-y. PMID: 37838650.
  8. Iny E*, Prakash I. ASO Author Reflections: Surgical Management of Phyllodes Tumors of the Breast. Ann Surg Oncol. 2023 Mar;30(3):1710-1711. doi: 10.1245/s10434-022-12922-1. PMID: 36463356.
  9. Moldoveanu D*, Iny E*, Theriault C*, Florea A, Wong SM, Meterissian S, Basik M, Boileau JF, Margolese R, Prakash I. Margin Status and Local Recurrence in Phyllodes Tumours of the Breast: A Canadian Series. [Abstract accepted for poster presentation at SSO 2022; manuscript in preparation].
  10. Wong SM, Ferroum A*, Apostolova C*, Al Hassan B*, Prakash I, Basik M, Boileau JF, Meterissian S, Wong N, Foulkes WD. Incidence of occult breast cancer in BRCA1/2 and other high penetrance mutation carriers undergoing prophylactic mastectomy: when is sentinel lymph node biopsy indicated? [Abstract accepted for poster presentation at SSO 2022; manuscript submitted to Ann Surg Oncol].
  11. Prakash I, Neely NB, Thomas SM, Sammons S, Blitzblau RC, DiLalla GA, Hyslop T, Menendez CS, Plichta JK, Rosenberger LH, Fayanju OM, Hwang ES, Greenup RA. Utilization of Neoadjuvant Chemotherapy in High-risk, Node-negative Early Breast Cancer. Cancer Med. 2022 Feb;11(4):1099-1108. doi: 10.1002/cam4.4517. Epub 2022 Jan 5. PMID: 34989142.
  12. Di Lena, É*, Hopkins, B, Wong, SM, & Meterissian, S. (2022). Delays in operative management of early-stage, estrogen receptor-positive breast cancer during the COVID-19 pandemic: A multi-institutional matched historical cohort study. Surgery, 171(3), 666–672. https://doi.org/10.1016/j.surg.2021.10.033. PMID: 34862071.
  13. Tejera D*, Rana M, Basik M, Boileau JF, Margolese R, Prakash I, Meguerditchian AN, Muanza T, Monette J, Wong SM. Population-based Analysis of Non-operative Management and Treatment Patterns in Older Women with Estrogen Receptor-positive Breast Cancer. Breast Cancer Res Treat. 2021 Dec;190(3):491-501. doi: 10.1007/s10549-021-06393-3. Epub 2021 Sep 20. PMID: 34542772.
  14. Wong SM, Ajjamada L, Weiss AC, Prakash I, Skamene S, Boileau JF, Pollak MN, Basik M. Clinicopathologic Features of Breast Cancers Diagnosed in Women Treated with Prior Radiation Therapy for Hodgkin Lymphoma: Results from a Population-based Cohort. Cancer. 2022 Apr 1;128(7):1365-1372. doi: 10.1002/cncr.34065. Epub 2021 Dec 17. PMID: 34919263.
  15. Di Lena E*, Prakash I, Meterissian S. Axilla: decision-making and planning. In: Breast Cancer Essentials: Perspectives for Surgeons. (2021); pp. 197-208. Switzerland: Springer International Publishing.
  16. Prakash I, Fayanju OM: Detection and diagnosis of metastatic breast cancer. A Practical Guide to Managing Breast Cancer for Low-Middle Income Countries. Chu QD, Klimberg VS, Anderson BO, Balch CM, Parker CC, Dedey F, Mendez J, Are C (eds.). Chicago: American College of Surgeons, 2021 [in press].
  17. Di Lena É*, Hopkins B, Wong SM, Meterissian S. Delays in Operative Management of Early-stage, Estrogen Receptor-positive Breast Cancer During the COVID-19 Pandemic: A Multi-institutional Matched Historical Cohort Study. Surgery. 2022 Mar;171(3):666-672. doi: 10.1016/j.surg.2021.10.033. Epub 2021 Oct 22. PMID: 34862071; PMCID: PMC8531248.
  18. Tejera D*, Rana M, Basik M, Boileau JF, Margolese R, Prakash I, Meguerditchian AN, Muanza T, Monette J, Wong SM. Population-based Analysis of Non-operative Management and Treatment Patterns in Older Women with Estrogen Receptor-positive Breast Cancer. Breast Cancer Res Treat. 2021 Dec;190(3):491-501. doi: 10.1007/s10549-021-06393-3. Epub 2021 Sep 20. PMID: 34542772.
  19. Wong SM, Basik M, Florianova L, Margolese R, Dumitra S, Muanza T, Carbonneau A, Ferrario C, Boileau JF. Oncologic Safety of Sentinel Lymph Node Biopsy Alone After Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2021 May;28(5):2621-2629. doi: 10.1245/s10434-020-09211-0. Epub 2020 Oct 23. PMID: 33095362.
  20. Tejera D*, Rana M, Basik M, Boileau JF, Margolese R, Prakash I, Meguerditchian AN, Muaza T, Monette J, Wong SM. Population-Based Analysis of Nonoperative Management and Treatment Patterns in Older Women with Estrogen Receptor-Positive Breast Cancer. Breast Cancer Res Treat. 2021 Sep 20. doi: 10.1007/s10549-021-06393-3. PMID: 34542772.
  21. Greenup RA, Prakash I, Sorenson C. "Choosing Wisely" in Breast Cancer Surgery: Drivers of Low Value Care. Ann Surg Oncol. 2020 Aug;27(8):2577-2579. doi: 10.1245/s10434-020-08584-6. Epub 2020 May 15. PMID: 32415352.

 

Back to top